Most financial news isn't created with the purpose of producing good investment decisions. It is designed to provide information in an engaging way while creating a constant sense of needing to act. This year offers plenty of examples. The latest is the recent initial public offering of Robinhood Markets (NASDAQ: HOOD) , the online brokerage that positions itself as the platform of the people. Is it a greedy company manipulating inexperienced investors or the future of finance for the internet generation? There are strong opinions on both sides of the argument.
But there is no penalty for skipping the debate. As investors, we can simply ignore the complicated stocks and focus on companies that are easier to understand. To that end, three Fool contributors were asked to highlight one healthcare company they think is a better buy than Robinhood. They chose Inari Medical (NASDAQ: NARI) , AbbVie (NYSE: ABBV) , and Illumina (NASDAQ: ILMN) . Here's why.
Image source: Getty Images.
For further details see:
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys